BXRXQ — Baudax Bio Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $13.91m
- $1.27m
Baudax Bio plunges on $4.2 mln registered direct offering
Brief: Baudax Bio Announces $4.2 Million Registered Direct Offering
Brief: Baudax Bio Announces $4.2 Mln Registered Direct Offering
Brief: Baudax Bio Says Co Was Not In Compliance With Nasdaq Listing Rule 5550(A)(2)
Brief: Baudax Bio Announces Clinical Program Update For Neuromuscular Blocking Agents
Baudax Bio Inc reports results for the quarter ended in September - Earnings Summary
Brief: Baudax Bio Reports Third Quarter 2021 Financial Results And Business Highlights
Baudax Bio Inc reports results for the quarter ended in June - Earnings Summary
Baudax Bio Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: Baudax Bio Inc - Iss Recommends Baudax Bio Shareholders Vote "For" Proposed Additional Authorized Shares At Upcoming Special Meeting Of Shareholders
Brief: Baudax Bio Announces $11.9 Mln Registered Direct Offering
Brief: Baudax Bio Announces Publication Of Phase IIIB Anjeso Data In The Journal Pain Management
Baudax Bio Inc reports results for the quarter ended in March - Earnings Summary
Brief: Baudax Bio Reports First Quarter 2021 Financial Results
Brief: Baudax Bio Announces Publication Of Phase Iiib Data On Preoperative Administration Of Anjeso® In Patients Undergoing Total Knee Arthroplasty (Tka) In Pain Medicine
U.S. RESEARCH ROUNDUP- Anterix, Oshkosh, Southern Copper
Brief: Baudax Bio Inc Files For Mixed Shelf Of Upto $100 Million
Brief: Baudax Bio Says Secured About $55 Million In Gross Proceeds From Equity Offerings Over Past 4 Months
U.S. RESEARCH ROUNDUP- Akamai Technologies, Super League Gaming, Twitter